Thanks Mozz but you're fully invested here so potentially more suspectible to glossing over market realities.
PR has made himself a wealthy man by most metrics based on SHAREHOLDERs capital and NOT his own risked capital. He did take a $10m payday already from the sale of his board allocated shares. Admittedly he has purchased on market but only took up 20% of his allocation recently and not "50%" which he indicated in a webinar
All these consultants are great but will any drive outcomes we now need with the FDA? Based on IND and P3 staging I'm not convinced they can.
Having a founder be fully invested is a positive BUT you also need one that the market believes in.
Clock is ticking and the jury is certainly out on the direction PR has taking PAR in
Thanks Mozz but you're fully invested here so potentially...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $288.5K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130626 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |